Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Metagenomi, Inc. - Common Stock (NQ: MGX )

4.760 -0.010 (-0.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 140,188
Open 4.760
Bid (Size) 4.620 (3)
Ask (Size) 4.770 (1)
Prev. Close 4.770
Today's Range 4.460 - 4.960
52wk Range 3.340 - 12.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire

Performance

YTD
-53.83%
-53.83%
1 Month
+25.26%
+25.26%
3 Month
-28.74%
-28.74%
6 Month
-53.83%
-53.83%
1 Year
-53.83%
-53.83%

More News

Read More
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)
From Kirby McInerney LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Via InvestorPlace
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
From Metagenomi, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Metagenomi to Present at Upcoming Scientific Meetings
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
From Metagenomi Technologies, LLC
Via GlobeNewswire
This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Metagenomi Announces Closing of Initial Public Offering
From Metagenomi Technologies, LLC
Via GlobeNewswire
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.